In a patient with a deep thigh hematoma after trauma and an elevated erythrocyte sedimentation rate, elevated C‑reactive protein, and normal white blood cell count, could this be polymyositis?

No, this is not polymyositis—this presentation is consistent with an inflammatory response to the deep thigh hematoma from trauma.

In a patient with recent trauma and a documented deep thigh hematoma, mildly elevated inflammatory markers (ESR 32, CRP 2.95) with normal WBC represent an expected physiological response to tissue injury and blood breakdown, not an autoimmune myopathy.

Why This Is Not Polymyositis

Clinical Context Excludes the Diagnosis

• Polymyositis requires progressive, symmetric proximal muscle weakness as the defining clinical feature 12
• A post-traumatic hematoma with localized inflammation does not meet diagnostic criteria
• The temporal relationship (trauma → hematoma → inflammatory markers) points to reactive inflammation, not primary autoimmune disease

Laboratory Findings Are Non-Specific

Your inflammatory markers are only mildly elevated and non-diagnostic:

• ESR of 32 mm/hr is minimally elevated and commonly seen with tissue injury, hematomas, or any inflammatory process 3
• CRP of 2.95 mg/dL is mildly elevated but far below levels typically associated with active inflammatory myopathy 4
• Normal WBC argues against active infection or acute inflammatory disease

In polymyositis patients, laboratory abnormalities are much more pronounced 4:

• Creatine kinase elevated in 51% (often markedly so)
• Aldolase elevated in 65%
• Transaminases (ALT/AST) elevated in 43-51%
• ESR elevated in only 33% of cases—it's not a sensitive marker for myositis 45

What You're Actually Seeing

The mildly elevated inflammatory markers reflect:

• Tissue breakdown from the hematoma
• Local inflammatory response to blood products
• Normal healing physiology after trauma

This is fundamentally different from the immune-mediated muscle destruction in polymyositis.

Critical Diagnostic Requirements for Polymyositis

If you were genuinely concerned about polymyositis, you would need 12:

1. Clinical features: Progressive symmetric proximal muscle weakness (difficulty rising from chair, climbing stairs, lifting arms)
2. Elevated muscle enzymes: CK, aldolase, LDH (often 5-50× normal)
3. Myositis-specific autoantibodies: Anti-Jo-1, anti-PL-12, anti-SRP, anti-Mi-2
4. Muscle biopsy (gold standard): Endomysial inflammation, MHC-I upregulation, CD8+ T-cell infiltration
5. EMG findings: Myopathic pattern

None of these are present or indicated in your trauma patient.

Common Pitfall to Avoid

Do not order myositis panels or pursue inflammatory myopathy workup in patients with:

• Clear traumatic etiology
• Localized pathology (hematoma)
• Only mildly elevated non-specific inflammatory markers
• No clinical features of muscle weakness

This leads to unnecessary testing, false-positive autoantibodies, patient anxiety, and potential misdiagnosis.

What to Do Instead

Monitor the hematoma clinically:

• Expect inflammatory markers to normalize as the hematoma resolves (typically 2-4 weeks)
• Repeat ESR/CRP in 2-3 weeks if clinically indicated
• Watch for complications: compartment syndrome, infection (would see elevated WBC, fever), or expanding hematoma

Only pursue myositis workup if:

• Patient develops true proximal muscle weakness unrelated to pain/trauma
• CK becomes markedly elevated (>1000 U/L) without clear cause
• Inflammatory markers remain elevated after hematoma resolution
• New systemic symptoms emerge (rash, dysphagia, respiratory weakness)